Tata Capital Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI Listing Regulations.
TATACAP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tata Capital Limited has informed the exchanges that Tata Capital Healthcare Fund III (TCHF III), a SEBI-registered Category II Alternative Investment Fund focused on healthcare and life sciences private equity in India, has declared its first close on February 20, 2026. Consequent to this, TCHF III has become a subsidiary of Tata Capital. Separately, Tata Capital Healthcare III General Partners LLP (a Singapore-registered partnership acting as general partner of TCL's overseas fund in Singapore) has also become a 100% subsidiary of Tata Capital Pte. Ltd., which is a wholly-owned Singapore-based subsidiary of Tata Capital. The turnover of both entities is currently Nil, and no cash or share consideration was involved as the entities were newly incorporated as part of TCL's fund strategy.
This is an internal group-level consolidation linked to the launch of the third Tata Capital Healthcare Fund. There is no impact on shareholder equity or share price, but it signals expansion of Tata Capital's healthcare-focused private equity franchise, which could support future AUM growth and fee income.